Abstract
This latest Multi Client Publication from HBS Consulting provides:
- An overview of current industry-landscape for molecular diagnostics within
the oncology area
- Analysis of the key European markets including forecasts for growth,
drivers and restraints in the marketplace
- Reimbursement and legislation environment, the most relevant national
guidelines relating to genetic testing
- Understanding of market opportunities for molecular diagnostics within the
oncology market as an area of growth, research and future developments
Overview
Project Objectives
The primary objective of this report, compiled from an analysis of primary and
secondary research data, is to provide an overview of the molecular
diagnostics market for selected oncology markers in the country markets listed
below.
- France
- Germany
- Italy
- United Kingdom
- USA
The following key issues have been addressed:
- Provide a reflective picture of the type and number of relevant testing
institutions
- Which and how many parameters are tested (market size). Top 3 solid
markers, top 3 lymphoid markers and emerging markers identified.
- Which assays are used (home brew or commercial)
- Current market growth per parameter
- Expected market growth rates per parameter in the next 5 years
- Which technologies are used (PCR, RT-PCR, FISH, sequencing, microarrays,
others) and what is the anticipated shift in use of these.
- Devices used
- The regulatory issues per country (legislation, reimbursement etc.)
- Future trends & emerging technologies
View Cart
